In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria.
about
Roles of d-Amino Acids on the Bioactivity of Host Defense PeptidesNew horizons for host defense peptides and lantibioticsDe novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications.Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.Acinetobacter baumannii: emergence of a successful pathogenPiscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse modelPredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptides.The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia.Therapeutic options for Acinetobacter baumannii infections.Host defense peptides in wound healing.De novo designed synthetic mimics of antimicrobial peptides.Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI.Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffoldRoad to clinical efficacy: challenges and novel strategies for antimicrobial peptide development.Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.Therapeutic options for Acinetobacter baumannii infections: an update.New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.Lactoferricin Peptides Increase Macrophages' Capacity To Kill Mycobacterium avium.Biodegradable Antimicrobial Polycarbonates with In Vivo Efficacy against Multidrug-Resistant MRSA Systemic Infection.Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering.Hydrocarbon Stapled Antimicrobial Peptides.The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity.Unraveling the bioactivity of anticancer peptides as deduced from machine learningEfficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumanniiAntimicrobial peptide modification of biomaterials using supramolecular additives
P2860
Q26744734-2B4EDCF5-118D-4999-9651-62BB31DA52E2Q26997072-E74525FE-8412-4585-9070-3298321A92BFQ33598664-7C804B80-8554-4635-BA2C-D6A750356249Q34234867-4A2F2B45-771C-48B5-B52C-EC71FBB484D8Q34510497-B04B612F-E976-4ABC-82D3-F1EB57F6FDCEQ34795807-6B2A334F-ED65-453E-BF6F-244470D21D14Q35548903-3795445D-76BC-4DBB-B265-30675EDE2C6DQ35682704-4A8BF3FA-FB80-4F6E-9C50-B7233C656C05Q35905605-B773805E-2968-4795-83FC-BE86931C79F3Q36018591-6A4BEEAC-1FAE-4C32-8EFE-B3FA2E6534B3Q36646981-48C2042D-DE09-45EC-8D19-8C9CF787EC0CQ37099006-1867DEF7-9934-412F-8C22-AF13811ED7EAQ37127271-4B979764-3D1C-43C8-B320-A8B3A86F3938Q37321460-D0D44D35-779E-4DC4-AE6B-79930F9268F0Q37453121-76A5D49D-B482-4490-96F5-B12383F55735Q37566506-F0E6BDCE-BB69-44B9-9DE8-31E7252BC370Q37778941-31388AEA-B456-4D5E-BCFE-DAB3624BBB11Q37894693-5FFFE887-2322-4E79-91B6-8B7242F47438Q38008459-EDEF9657-D872-4242-B8FB-D80C52A7CD0FQ38049332-19D6BC10-5A39-432E-AB03-948866ABDDBBQ38805100-E58ABED8-1371-4072-B010-D47938FCF1DCQ39250554-94BF0E1E-B551-4A69-B2D2-028CCB52BE47Q40065379-F8C365FF-EFC4-4796-BB8B-4C5AEF4DCC99Q40583200-686E6F70-D146-4492-B5D0-6DB57BAE1B16Q41916247-BC8BFCEE-BA88-4B53-8E8D-3EC62D4FF62DQ48250595-EFCC9D2C-1178-4697-8D09-553759772884Q50889058-CC3258A5-0D3C-4B4C-A9E4-56FBACFFD66DQ57174709-592E474C-A3FE-4D77-A9D3-9AAD5B516A5AQ57179932-49105A7F-FA0C-49BC-A22E-B6EB8E464CDFQ57822926-B82C7461-0323-4DC2-A0EF-C07FDB6CB978
P2860
In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vitro activity and potency ...... n mice infected with bacteria.
@ast
In vitro activity and potency ...... n mice infected with bacteria.
@en
type
label
In vitro activity and potency ...... n mice infected with bacteria.
@ast
In vitro activity and potency ...... n mice infected with bacteria.
@en
prefLabel
In vitro activity and potency ...... n mice infected with bacteria.
@ast
In vitro activity and potency ...... n mice infected with bacteria.
@en
P2093
P2860
P1476
In vitro activity and potency ...... n mice infected with bacteria.
@en
P2093
Amir Braunstein
Yechiel Shai
P2860
P304
P356
10.1128/AAC.48.8.3127-3129.2004
P407
P577
2004-08-01T00:00:00Z